Fundraising FoxOmega Ophthalmics
Versailles, US · Kentucky LLC
Find your way into Omega Ophthalmics
Sign up to see every warm intro you have to Omega Ophthalmics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Omega Ophthalmics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Omega Ophthalmics develops the Gemini Capsule, an implantable device that maintains the capsular bag in an open configuration after cataract removal and provides a stable position for intraocular lens implantation. The product is used in ophthalmic surgery.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$1M disclosed across 3 rounds · 2022–2026
▶$320KraisedJan 2026 · 3 investors · OtherRule 506(b)
▶$320KraisedJan 2026 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Gary N WortzExecutive Officer, Director
- Rick W IflandExecutive Officer, Director
- Offering amount
- $9.6M
- Amount sold
- $320K
- Minimum investment
- $50K
- Proceeds to insiders
- $600K
- First sale
- Jan 2026
- Incorporated
- Limited Liability Company, Kentucky
- Federal exemptions
- 06b
▶$250KraisedJan 2025 · 2 investors · OtherRule 506(b)
▶$250KraisedJan 2025 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Rick W IflandExecutive Officer, Director
- Gary N WortzExecutive Officer, Director
- Offering amount
- $64M
- Amount sold
- $250K
- Minimum investment
- $50K
- Proceeds to insiders
- $600K
- First sale
- Dec 2024
- Incorporated
- Limited Liability Company, Kentucky
- Federal exemptions
- 06b
▶$450KraisedJul 2022 · 2 investors · OtherRule 506(b)
▶$450KraisedJul 2022 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Rick W IflandExecutive Officer, Director
- Gary N WortzExecutive Officer, Director
- Offering amount
- $3.2M
- Amount sold
- $450K
- Minimum investment
- $50K
- Proceeds to insiders
- $600K
- First sale
- Jul 2022
- Incorporated
- Limited Liability Company, Kentucky
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
DoximityDoximity is the largest verified network of healthcare professionals in the U.S., connecting physicians, PAs, NPs, pharmacists, and medical students across specialties and care settings. The platform provides mobile-first tools for clinical communication, collaboration, and workflow optimization.
OisOIS is a conference and community, active since 2009, focused on eye care and ophthalmology innovation, connecting startups, strategics, investors, and clinicians. It provides curated programming, networking, and access to new technologies in the ophthalmology industry.
ZocdocZocdoc runs an online marketplace where US patients find in-network doctors and dentists and book in-person or telehealth appointments.
SharecareSharecare provides AI-powered health navigation for employers and health plans, connecting employees' health questions to their available benefits and appropriate care options. The platform surfaces relevant wellness programs, chronic condition management, and advocacy services within employees' moment of need.
PractoPracto operates an online healthcare platform offering a directory of verified doctors, appointment booking at hospitals and clinics, online consultations across 20+ specialities, subscription health plans, diagnostic test collection, and medicine delivery. It also provides practice management and hospital information management software for clinics and hospitals.
Companies working in the same space as Omega Ophthalmics.
In the news
Frequently asked questions
- What does Omega Ophthalmics do?
- Omega Ophthalmics develops the Gemini Capsule, an implantable device that maintains the capsular bag in an open configuration after cataract removal and provides a stable position for intraocular lens implantation. The product is used in ophthalmic surgery.
- Who founded Omega Ophthalmics?
- Omega Ophthalmics was founded by Rick W Ifland, Gary N Wortz.
- How much funding has Omega Ophthalmics raised?
- Omega Ophthalmics has disclosed $1M raised across 3 rounds.
- Where is Omega Ophthalmics headquartered?
- Omega Ophthalmics is headquartered in Versailles, US.